Deadline coming up on Nov. 13th in Lawsuit for Investors in shares of Integra LifeSciences Holdings Corporation (NASDAQ: IART)

A deadline is coming up on November 13, 2023, in the lawsuit filed for certain investors of Integra LifeSciences Holdings Corporation (NASDAQ: IART) over alleged securities laws violations by Integra LifeSciences Holdings Corporation.

Investors who purchased shares of Integra LifeSciences Holdings Corporation (NASDAQ: IART) have certain options and there are strict and short deadlines running. Deadline: November 13, 2023. NASDAQ: IART stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

According to the complaint filed in the U.S. District Court for the District of New Jersey the plaintiff alleges on behalf of purchasers of Integra LifeSciences Holdings Corporation (NASDAQ: IART) common shares between March 11, 2019 and May 22, 2023, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between March 11, 2019 and May 22, 2023, the defendants failed to disclose to investors that Integra had failed to take sufficient measures to remediate the violations identified by the FDA in the 2018 Form 483, 2019 Warning Letter, and the 2021 Form 483, that as a result of those deficiencies, since March 2018, all products manufactured in the Boston Facility had the potential for higher-than-permitted levels of endotoxin and would need to be recalled, that the Company was not making progress towards obtaining its PMA indication for SurgiMend, in part, because the manufacturing site that would produce the PMA product, the Boston Facility, was in continued violation of the FDA standards that Integra failed to rectify years after the initial notice of the violations and as a result the facility had to be shutdown to correct those ongoing deficiencies, and that as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

Those who purchased shares of Integra LifeSciences Holdings Corporation (NASDAQ: IART) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.